Perseus Proteomics (TSE:4882) Total Liabilities : 円241.10 Mil (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Perseus Proteomics Total Liabilities?

Perseus Proteomics's Total Liabilities for the quarter that ended in Dec. 2023 was 円241.10 Mil.

Perseus Proteomics's quarterly Total Liabilities increased from Jun. 2023 (円167.66 Mil) to Sep. 2023 (円205.84 Mil) and increased from Sep. 2023 (円205.84 Mil) to Dec. 2023 (円241.10 Mil).

Perseus Proteomics's annual Total Liabilities increased from Mar. 2021 (円34.91 Mil) to Mar. 2022 (円148.38 Mil) and increased from Mar. 2022 (円148.38 Mil) to Mar. 2023 (円170.11 Mil).

Perseus Proteomics Total Liabilities Historical Data

The historical data trend for Perseus Proteomics's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Perseus Proteomics Total Liabilities Chart

Perseus Proteomics Annual Data

Trend

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Total Liabilities

Get a 7-Day Free Trial

32.55

62.00

34.91

148.38

170.11

Perseus Proteomics Quarterly Data
	Mar18	Mar19	Dec19	Mar20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Total Liabilities	Get a 7-Day Free Trial												134.34	170.11	167.66	205.84	241.10

Perseus Proteomics Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Perseus Proteomics's Total Liabilities for the fiscal year that ended in Mar. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	111.117	+	(0	+	58.988
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	170.11

Total Liabilities	=	Total Assets (A: Mar. 2023 )	-	Total Equity (A: Mar. 2023 )
	=	2566.65	-	2396.545
	=	170.11

Perseus Proteomics's Total Liabilities for the quarter that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	99.615	+	(0	+	141.488
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	241.10

Total Liabilities	=	Total Assets (Q: Dec. 2023 )	-	Total Equity (Q: Dec. 2023 )
	=	1796.664	-	1555.561
	=	241.10

Perseus Proteomics Total Liabilities Related Terms

Thank you for viewing the detailed overview of Perseus Proteomics's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Perseus Proteomics (TSE:4882) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Perseus Proteomics Inc (TSE:4882) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

4-7-6, Komaba, Tokyo Park Building, Meguro-ku, Tokyo, JPN, 153-0041

Website

https://www.ppmx.com

Perseus Proteomics Inc is engaged in the research and development, manufacture, and sales of pharmaceuticals. It provides antibody based therapeutics and diagnostics drugs to cure against cancer and other diseases.

Perseus Proteomics (TSE:4882) Headlines

No Headlines